130 related articles for article (PubMed ID: 29168243)
21. Intravenous iron sucrose for children with iron deficiency anemia: a single institution study.
Mantadakis E; Tsouvala E; Xanthopoulou V; Chatzimichael A
World J Pediatr; 2016 Feb; 12(1):109-13. PubMed ID: 25754747
[TBL] [Abstract][Full Text] [Related]
22. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
Mahey R; Kriplani A; Mogili KD; Bhatla N; Kachhawa G; Saxena R
Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
[TBL] [Abstract][Full Text] [Related]
23. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD).
Fütterer S; Andrusenko I; Kolb U; Hofmeister W; Langguth P
J Pharm Biomed Anal; 2013 Dec; 86():151-60. PubMed ID: 23998966
[TBL] [Abstract][Full Text] [Related]
24. Iron polymaltose complexes: Could we spot physicochemical differences in medicines sharing the same active pharmaceutical ingredient?
Di Francesco T; Delafontaine L; Philipp E; Lechat E; Borchard G
Eur J Pharm Sci; 2020 Feb; 143():105180. PubMed ID: 31841697
[TBL] [Abstract][Full Text] [Related]
25. Parenteral iron therapy options.
Silverstein SB; Rodgers GM
Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.
Schnorr J; Fütterer S; Spicher K; Catarinolo M; Schlösser C; Enzmann H; Langguth P
Regul Toxicol Pharmacol; 2018 Apr; 94():293-298. PubMed ID: 29454888
[TBL] [Abstract][Full Text] [Related]
27. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
Winkelmayer WC; Goldstein BA; Mitani AA; Ding VY; Airy M; Mandayam S; Chang TI; Brookhart MA; Fishbane S
Am J Kidney Dis; 2017 Jun; 69(6):771-779. PubMed ID: 28063734
[TBL] [Abstract][Full Text] [Related]
28. Nanomedicines in clinical practice: Are colloidal iron sucrose ready-to-use intravenous solutions interchangeable?
Di Francesco T; Sublet E; Borchard G
Eur J Pharm Sci; 2019 Apr; 131():69-74. PubMed ID: 30742979
[TBL] [Abstract][Full Text] [Related]
29. The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
Macdougall IC; Dahl NV; Bernard K; Li Z; Batycky A; Strauss WE
BMC Nephrol; 2017 Apr; 18(1):117. PubMed ID: 28372549
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
[TBL] [Abstract][Full Text] [Related]
31. The similarity question for biologicals and non-biological complex drugs.
Crommelin DJ; Shah VP; Klebovich I; McNeil SE; Weinstein V; Flühmann B; Mühlebach S; de Vlieger JS
Eur J Pharm Sci; 2015 Aug; 76():10-7. PubMed ID: 25912826
[TBL] [Abstract][Full Text] [Related]
32. Potential of Alginate Encapsulated Ferric Saccharate Microemulsions to Ameliorate Iron Deficiency in Mice.
Mukhija K; Singhal K; Angmo S; Yadav K; Yadav H; Sandhir R; Singhal NK
Biol Trace Elem Res; 2016 Jul; 172(1):179-192. PubMed ID: 26637994
[TBL] [Abstract][Full Text] [Related]
33. Response to iron sucrose in dialysis patients sensitive to iron dextran.
Gupta A; Khaira A; Dogra M; Agarwal SK
Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):744-5; author reply 745. PubMed ID: 20587886
[No Abstract] [Full Text] [Related]
34. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
Sane R; Baribeault D; Rosenberg CL
Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
[TBL] [Abstract][Full Text] [Related]
35. Intravenous iron sucrose--an effective and attractive modality for perioperative anaemia management.
Froessler B; Papendorf D
Anaesth Intensive Care; 2010 Sep; 38(5):960-2. PubMed ID: 20865896
[No Abstract] [Full Text] [Related]
36. Part 1: Physicochemical characterization of bevacizumab in undiluted 25 mg/mL drug product solutions: Comparison of originator with a biosimilar candidate.
Arvinte T; Palais C; Poirier E; Cudd A; Rajendran S; Brokx S; Dowd J
J Pharm Biomed Anal; 2019 Oct; 175():112742. PubMed ID: 31344647
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Iron Sucrose versus Oral Iron in the Treatment of Pregnancy with Iron Deficiency Anaemia: A Systematic Review.
Shi Q; Leng W; Wazir R; Li J; Yao Q; Mi C; Yang J; Xing A
Gynecol Obstet Invest; 2015; 80(3):170-8. PubMed ID: 25824489
[TBL] [Abstract][Full Text] [Related]
38. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
Shi Q; Li J; Yao Q; Mi C; Yang J; Xing A
Ann Hematol; 2015 Mar; 94(3):523-5. PubMed ID: 25123238
[No Abstract] [Full Text] [Related]
39. [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study].
Li H; Wang SX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):457-62. PubMed ID: 19567093
[TBL] [Abstract][Full Text] [Related]
40. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy.
Wali A; Mushtaq A; Nilofer
J Pak Med Assoc; 2002 Sep; 52(9):392-5. PubMed ID: 12532571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]